Amphastar Pharmaceuticals
AMPH
AMPH
255 hedge funds and large institutions have $1.47B invested in Amphastar Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 90 increasing their positions, 93 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
3% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 93
18% less capital invested
Capital invested by funds: $1.8B → $1.47B (-$332M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
255
Holding in Top 10
1
Calls
$1.25M
Puts
$1.19M
Top Buyers
| 1 | +$8.43M | |
| 2 | +$7.89M | |
| 3 | +$6.8M | |
| 4 |
Renaissance Technologies
New York
|
+$5.08M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$4.42M |
Top Sellers
| 1 | -$9.3M | |
| 2 | -$6.9M | |
| 3 | -$5.75M | |
| 4 |
PCM
Penserra Capital Management
Orinda,
California
|
-$3.69M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$3.5M |